End of phase I results of ZUMA-3, a phase 1/2 study of KTE-X19, anti-CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients (pts) with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL).

被引：0
|
作者：
Shah, Bijal D.
Bishop, Michael Russell
Oluwole, Olalekan O.
Logan, Aaron
Baer, Maria R.
Donnellan, William Bruce
Carr-O'Dwyer, Kristen Marie
Holmes, Houston
Arellano, Martha Lucia
Ghobadi, Armin
Pagel, John M.
Lin, Yi
Cassaday, Ryan Daniel
Park, Jae Hong
Mardiros, Armen
Shen, Tong
Goyal, Lovely
Vezan, Remus
Jain, Rajul K.
Wierda, William G.
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[3] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[4] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA
[5] Univ Maryland, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA
[6] Sarah Cannon Res Inst, Nashville, TN USA
[7] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[8] Texas Oncol, Baylor Charles A Sammons Canc Ctr, Dallas, TX USA
[9] Winship Canc Inst, Atlanta, GA USA
[10] Washington Univ, Sch Med, St Louis, MO USA
[11] Siteman Canc Ctr, St Louis, MO USA
[12] Swedish Canc Inst, Seattle, WA USA
[13] Mayo Clin, Rochester, MN USA
[14] Univ Washington, Sch Med, Seattle, WA USA
[15] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[16] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[17] Kite, Santa Monica, CA USA
[18] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7006
引用
收藏
页数：2
相关论文
共 50 条
  • [21] KTE-X19, an anti-CD19 chimeric antigen receptor T-cell therapy, in patients with relapsed/refractory mantle cell lymphoma: results from phase 2 of ZUMA-2
    Wang, M.
    Munoz, J.
    Goy, A.
    Locke, F.
    Jacobson, C.
    Hill, B.
    Timmerman, J.
    Holmes, H.
    Jaglowski, S.
    Flinn, I.
    McSweeney, P.
    Miklos, D.
    Pagel, J.
    Kersten, M. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 28 - 29
  • [22] ZUMA-3: A phase 1/2 multi-center study evaluation the safety and efficacy of KTE-C19 anti-CD19 CAR T cells in adult patients with relapsed/refractory B precursor acute lymphoblastic leukemia (R/R ALL)
    Shah, B.
    Castro, J.
    Goekbuget, N.
    Kersten, M. Jose
    Hagenbeek, T.
    Wierda, W.
    Schiller, G.
    Bot, A.
    Rossi, J. M.
    Jiang, Y.
    Navale, L.
    Stout, S.
    Aycock, J.
    Wiezorek, J.
    Jain, R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [23] ZUMA-4 preliminary results: phase 1 study of KTE-C19 chimeric antigen receptor T cell therapy in pediatric and adolescent patients (pts) with relapsed/refractory acute lymphoblastic leukemia (R/R ALL)
    Lee, D. W.
    Wayne, A. S.
    Huynh, V.
    Handgretinger, R.
    Pieters, R.
    Michele, G.
    Baruchel, A.
    Feuchtinger, T.
    Bertrand, Y.
    Hemiston, M.
    Brown, P. A.
    Rossi, J.
    Jiang, Y.
    Navale, L.
    Stout, S.
    Aycock, J.
    Mardiros, A.
    Wiezorek, J.
    Jain, R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [24] ZUMA-4 PHASE 1: KTE-X19, AN ANTI-CD19 CAR T CELL THERAPY, IN CHILDREN AND ADOLESCENTS WITH R/R B-ALL
    Wayne, Alan
    Van Huynh
    Hijiya, Nobuko
    Rouce, Rayne
    Brown, Patrick
    Krueger, Joerg
    Rytting, Michael
    Kitko, Carrie
    Dela Ziga, Edward
    Hermiston, Michelle
    Richards, Michael
    Baruchel, Andre
    Mardiros, Armen
    Shen, Tong
    Goyal, Lovely
    Vezan, Remuz
    Jain, Rajul
    Lee, Daniel
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [25] Production of Anti-CD19 CAR T Cells for ZUMA-3 and-4: Phase 1/2 Multicenter Studies Evaluating KTE-C19 in Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R ALL)
    Sabatino, Marianna
    Choi, Kenny
    Chiruvolu, Vijay
    Better, Marc
    BLOOD, 2016, 128 (22)
  • [26] 2-year update of KTE-X19 in adults with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) in ZUMA-3
    Shah, Bijal D.
    Ghobadi, Armin
    Oluwole, Olalekan O.
    Logan, Aaron C.
    Boissel, Nicolas
    Cassaday, Ryan D.
    Forcade, Edouard
    Bishop, Michael R.
    Topp, Max S.
    Tzachanis, Dimitrios
    O'Dwyer, Kristen M.
    Arellano, Martha L.
    Lin, Yi
    Baer, Maria R.
    Schiller, Gary J.
    Zhou, Lang
    Schuberth, Petra C.
    Masouleh, Behzad Kharabi
    Houot, Roch
    ANNALS OF ONCOLOGY, 2023, 34 : S1389 - S1389
  • [27] High Rates of Minimal Residual Disease-Negative (MRD-) Complete Responses (CR) in Adult and Pediatric and Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL) Treated With KTE-C19 (Anti-CD19 Chimeric Antigen Receptor [CAR] T Cells): Preliminary Results of the ZUMA-3 and ZUMA-4 Trials
    Shah, Bijal
    Van Huynh
    Sender, Leonard S.
    Lee, Daniel W., III
    Castro, Januario E.
    Wierda, William G.
    Dietz, Andrew C.
    Schiller, Gary J.
    Kersten, Marie Jose
    Handgretinger, Rupert
    Brown, Patrick
    Gore, Lia
    Goekbuget, Nicola
    Rosenthal, Joseph
    Sabatino, Marianna
    Bot, Adrian
    Rossi, John M.
    Jiang, Yizhou
    Navale, Lynn
    Stout, Shanna
    Aycock, Jeff S.
    Wiezorek, Jeff
    Jain, Rajul
    Wayne, Alan S.
    BLOOD, 2016, 128 (22)
  • [28] Optimizing chimeric antigen receptor (CAR) T cell therapy for adult patients with relapsed or refractory (r/r) acute lymphoblastic leukemia (ALL).
    Frey, Noelle V.
    Shaw, Pamela A.
    Hexner, Elizabeth O.
    Gill, Saar
    Marcucci, Katherine
    Luger, Selina M.
    Mangan, James K.
    Grupp, Stephan A.
    Maude, Shannon L.
    Ericson, Solveig
    Levine, Bruce
    Lacey, Simon F.
    Melenhorst, Jan J.
    June, Carl H.
    Porter, David L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] Phase 1 Results of CNCT19: CD19 CAR Constructed of a New Anti-CD19 Chimeric Antigen Receptor in Relapsed or Refractory Acute Lymphoblastic Leukemia
    Gu, Runxia
    Liu, Fang
    Zou, Dehui
    Liu, Bingcheng
    Liu, Wei
    Chen, Xiaojuan
    Liu, Kaiqi
    Guo, Ye
    Gong, Xiaoyuan
    Lv, Rui
    Chen, Xia
    Zhou, Chunlin
    Zhong, Mengjun
    Xu, Yingxi
    Wang, Huijun
    Wei, Hui
    Mi, Yingchang
    Qiu, Lugui
    Lv, Lulu
    Wang, Min
    Wang, Ying
    Zhu, Xiaofan
    Wang, Jianxiang
    BLOOD, 2019, 134
  • [30] UPDATED RESULTS FROM ZUMA-4: A PHASE 1/2 STUDY OF KTE-C19 CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY IN PEDIATRIC AND ADOLESCENT PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA
    Lee, D. W.
    Wayne, A. S.
    Huynh, V.
    Handgretinger, R.
    Brown, P. A.
    Pieters, R.
    Dietz, A. C.
    Pulsipher, M. A.
    Rossi, J.
    Mardiros, A.
    Jiang, Y.
    Navale, L.
    Aycock, J.
    Stout, S.
    Wiezorek, J.
    Jain, R.
    HAEMATOLOGICA, 2017, 102 : 346 - 347
12345